The New England Journal of Medicine

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...
The New England Journal of Medicine

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...
Gizmochina

Lenovo launches Erazer S130 2-in-1 PC with Intel N100, 13″ 3K display, DDR5 RAM & 6-7h battery life

Lenovo has introduced its new 2-in-1 PC tablet, the Erazer S130, designed to combine portability with practicality in a stylish, modern package. It is priced at 2,899 yuan ($396) for the 8GB+256GB ...
Gizmochina

Lenovo Tab: Affordable Tablet with 10.1″ Display, Helio G85, and 5,100mAh Battery

Lenovo has unveiled the Lenovo Tab, a budget-friendly tablet designed for users who need an affordable device for basic tasks. The Lenovo Tab has a clean and simple design with a single rear camera ...